Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_assertion description "[The objective of this study was to evaluate the effects of irbesartan, an angiotensin II receptor antagonist, on IAP in adolescents and young adults with type 1 diabetes and early signs of retinopathy and nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_assertion evidence source_evidence_literature NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_assertion SIO_000772 15983321 NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_assertion wasDerivedFrom befree-2016 NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_assertion wasGeneratedBy ECO_0000203 NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.
- befree-2016 importedOn "2016-02-19" NP501310.RAMHwc1AmPAZQOtma5Yo3SvhAH_n1Ev0h3ullZ2zG7xDc130_provenance.